Serum Level of Anti-Nucleocapsid, but Not Anti-Spike Antibody, Is Associated with Improvement of Long COVID Symptoms.

Varnai, Reka; Molnar, Tihamer; Zavori, Laszlo; Tokés-Füzesi, Margit; Illes, Zsolt; Kanizsai, Andrea; Csecsei, Peter

Varnai, Reka; Molnar, Tihamer; Zavori, Laszlo; Tokés-Füzesi, Margit; Illes, Zsolt; Kanizsai, Andrea; Csecsei, Peter.

Afiliação

Varnai R; Department of Primary Health Care, Medical School, University of Pecs, 7624 Pecs, Hungary.
Molnar T; Department of Anaesthesiology and Intensive Care, Medical School, University of Pecs, 7624 Pecs, Hungary.
Zavori L; Salisbury NHS Foundation Trust, Salisbury SP28BJ, UK.
Tokés-Füzesi M; Department of Laboratory Medicine, Medical School, University of Pecs, 7624 Pecs, Hungary.
Illes Z; Department of Neurology, Odense University Hospital, University of Southern Denmark, 5230 Odense, Denmark.
Kanizsai A; Department of Dentistry, Medical School, University of Pecs, 7624 Pecs, Hungary.
Csecsei P; Department of Neurosurgery, Medical School, University of Pecs, 7624 Pecs, Hungary.

Vaccines (Basel) ; 10(2)2022 Jan 21.

Article em En | MEDLINE | ID: mdl-35214624

Palavras-chave

fatigue; long COVID; nucleocapsid; spike; vaccination

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Hungria

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google